Bayer Cropscience working capital

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
270.71×209.79×210.13×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
66.49×63.76×69.22×
140.63×91.47×92.66×
196.57×182.08×186.69×
2.41×2.43×2.21×
1.04×1.11×1.10×
1.56×—1.29×
1.23×—1.00×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAYERCROP₹3,289.80

Bayer Cropscience Ltd.

· Chemicals
₹ CrorePeersUPLPIINDRALLISATULSHKANURASCAMLINFINECLEAN
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Inventory Days (DIO)—210.13209.79270.71
Receivable Days (DSO)—69.2263.7666.49
Payable Days (DPO)—92.6691.47140.63
Cash Conversion Cycle (days)—186.69182.08196.57
Working Capital Turnover—2.212.432.41
Asset Turnover—1.101.111.04
Cash Conversion (CFO/Net Income)—1.29—1.56
CFO/EBITDA—1.00—1.23
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.